<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>LSDP</provider_name><provider_url>https://www.lsdp.lt</provider_url><author_name>agrum-lsdp</author_name><author_url>https://www.lsdp.lt/author/agrum-lsdp/</author_url><title>Po J. Oleko kreipimosi - Briuselyje diskusijos d&#x117;l papildom&#x173; vakcin&#x173; skyrimo - LSDP</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="o7DmT774RL"&gt;&lt;a href="https://www.lsdp.lt/straipsniai/partijos-naujienos/po-j-oleko-kreipimosi-briuselyje-diskusijos-del-papildomu-vakcinu-skyrimo/"&gt;Po J. Oleko kreipimosi &#x2013; Briuselyje diskusijos d&#x117;l papildom&#x173; vakcin&#x173; skyrimo&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.lsdp.lt/straipsniai/partijos-naujienos/po-j-oleko-kreipimosi-briuselyje-diskusijos-del-papildomu-vakcinu-skyrimo/embed/#?secret=o7DmT774RL" width="600" height="338" title="&#x201C;Po J. Oleko kreipimosi &#x2013; Briuselyje diskusijos d&#x117;l papildom&#x173; vakcin&#x173; skyrimo&#x201D; &#x2014; LSDP" data-secret="o7DmT774RL" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://www.lsdp.lt/wp-content/uploads/2022/04/20191207SandD2018-750x590-1.jpg</thumbnail_url><thumbnail_width>750</thumbnail_width><thumbnail_height>590</thumbnail_height><description>Europos Komisijai pasiekus susitarim&#x105; su &#x201E;BioNTech-Pfizer&#x201C; d&#x117;l 10 milijon&#x173; papildom&#x173; COVID-19 vakcinos dozi&#x173;, Briuselyje prasid&#x117;jo diskusijos d&#x117;l j&#x173; paskirstymo ES &#x161;alims &#x2013; nar&#x117;ms. Dar sausio m&#x117;nes&#x12F; europarlamentarui Juozui Olekui atkreipus Europos Vadov&#x173; Tarybos bei Komisijos d&#x117;mes&#x12F; &#x12F; reikaling&#x105; didesn&#x12F; vakcin&#x173; kiek&#x12F; &#x161;alims, kurios susiduria su COVID-19 valdymo problemomis, &#x161;iuo metu Vadov&#x173; Taryboje aptariami galim&#x173; &#x201E;solidarumo [&hellip;]</description></oembed>
